Advanced Medical

On October 18, Advanced Medical Equipment S.A. presented its latest project, Cardio Breath, at the Warsaw Raffles Europejski Hotel, demonstrating how its diabetes technology can transform cardiology.

On October 18, Advanced Medical Equipment S.A. held an open presentation of its latest project, Cardio Breath, at the Warsaw Raffles Europejski Hotel, showing how its diabetes technology can revolutionize cardiology.

Diabetes mellitus involves high blood glucose levels due to insufficient insulin production, ineffective use, or no production by the pancreas.

The page lists key data and information about type 1 diabetes, including symptoms, causes, and coping strategies.

Advanced Medical Equipment S.A. is managed by people associated with medical technology and finance.

The company welcomes Pawel Kacprzak, a specialist in cardiology and internal medicine, as Medical Director.

Advanced Medical Equipment S.A. is founded by people connected to medicine, medical technology, and finance.

Advanced Medical Equipment S.A. is the full name of the company.

The company emphasizes transparency in actions and open communication with investors and shareholders.

The device measures blood sugar levels from breath and fits elegantly in a pocket.

Advanced Medical Equipment secures **PARP funding** to develop the **CardioBreath**, a monitor designed for patients with **heart failure**. The device integrates respiratory and cardiac data to improve diagnostic accuracy. The funding supports further research and commercialization efforts.

Sep 2026TipRanksNews article

Advanced Medical Equipment Spółka Akcyjna secures exclusive patent rights for its **Diabetomat** technology, a device likely used in diabetes management. The company now holds full control over intellectual property related to the system, reinforcing its position in medical equipment innovation.

Aug 2026TipRanksNews article

AME initiates clinical trials for **Diabetomatum**, leveraging its proprietary technology in a study of heart failure using the **Cardio Breath** device. The trial aims to explore the device’s role in monitoring or treating heart conditions. No additional details on trial scope, participants, or outcomes are provided.

Nov 2024Poland InsightNews article

AME debuts on the NewConnect stock exchange platform. The company secures its first public listing, expanding access to capital and investor opportunities.

Sep 2024DiabetomatNews article